FundedIQ
Biotechnology

AgeCurve: Funding, Investors & Team (Oct 2026)

AgeCurve offers kit sequences and quantifies thousands of human proteins to assess different aspects of their ongoing biological aging process.

www.agecurve.co.uk LinkedIn Cambridge, United Kingdom 1-10 employees
Total raised
$320k
Rounds
1
Latest
Seed
Feb 2024

AgeCurve has raised $320k across 1 funding round on record, the most recent a Seed of $320k announced in Feb 2024.

That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

AgeCurve Company Profile and Key Stats

Total funding raised
$320k
across 1 round on record
Funding rounds on record
1
Latest funding round
Seed
$320k in Feb 2024
Employees
1-10
reported band
Headquarters
Cambridge, United Kingdom

Latest funding round on record: Feb 2024.

AgeCurve Funding Rounds

Date
Round
Amount
Seed
$320k

AgeCurve Founders and Leadership Team

Name
Role
Contact
Attila Csordas
Founder
Locked

Contact details for the AgeCurve team: 1 of 1 has an email address on file.

Start 14-day free trial →

AgeCurve Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
5,343
$4.1M
16,970
$3.1M

AgeCurve's latest round of $320k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like AgeCurve in Biotechnology and Cambridge

Companies Similar to AgeCurve

R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…

Series A $3.0M

The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…

Undisclosed round $9.3M

Argonaute RNA company research projects build on existing intellectual property.

Undisclosed round $1.8M

An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…

Undisclosed round $1.8M

ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…

Undisclosed round $23.3M

Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…

Series A $33.6M

Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…

Undisclosed round $3.5M

Concert Bio helps businesses create optimal microbial communities.

Undisclosed round $130k

RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…

Series A $113M

N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…

Undisclosed round $3.6M

Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…

Undisclosed round $3.0M

Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.

Series A $32.5M

AgeCurve Funding FAQs

What does AgeCurve do?

AgeCurve offers kit sequences and quantifies thousands of human proteins to assess different aspects of their ongoing biological aging process.

How much funding has AgeCurve raised?

AgeCurve has raised $320k across 1 round on record. The most recent is a Seed of $320k announced in Feb 2024.

When did AgeCurve last raise funding?

AgeCurve's most recent funding round on record is a Seed of $320k, announced in Feb 2024.

Who founded AgeCurve?

FundedIQ lists Attila Csordas (Founder) at AgeCurve.

Where is AgeCurve headquartered?

AgeCurve is based in Cambridge, Cambridgeshire, United Kingdom.

How many employees does AgeCurve have?

AgeCurve is in the 1-10 employee band.

How does AgeCurve's funding compare to other Biotechnology startups?

AgeCurve's latest round of $320k is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's AgeCurve Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for AgeCurve is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.